Caroline Robert

Université Paris XI Sud - Gustave Roussy Cancer Campus

114 Rue Edouard Vaillant

94800 Villejuif

France

SCHOLARLY PAPERS

2

DOWNLOADS

24

CITATIONS

0

Scholarly Papers (2)

1.

Epacadostat Plus Pembrolizumab versus Placebo Plus Pembrolizumab in Patients with Unresectable or Metastatic Melanoma: Results of the Phase 3, Randomised, Double-Blind Echo-301/Keynote-252 Study

Number of pages: 39 Posted: 05 Feb 2019
The University of Sydney - Melanoma Institute Australia, University Hospital Zurich, Angeles Clinic and Research Institute, University of Chicago - Medical Center, Universidad del Desarrollo - Facultad de Medicina Clínica Alemana, University of Lyon 1, Hospital Clinic of Barcelona, The University of Sydney - Melanoma Institute Australia, Aix-Marseille University, Seoul National University - Seoul National Hospital, N.N. Blokhin Russian Cancer Research Center, Université Paris XI Sud - Gustave Roussy Cancer Campus, Royal Marsden NHS Foundation Trust, Merck & Co., Inc., Incyte Corporation, Incyte Corporation, Merck & Co., Inc. and University of Pennsylvania, Perelman School of Medicine, Abramson Family Cancer Research Institute
Downloads 22 (503,160)

Abstract:

Loading...

melanoma, indoleamine 2,3-dioxygenase, epacadostat, pembrolizumab, immunotherapy

2.

Immunological Cytopenia Induced by Anti-Programmed Cell Death (Ligand) 1 Antibodies

Number of pages: 29 Posted: 15 Sep 2018
Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Institut Universitaire du Cancer, Hôpitaux de Paris (AP-HP) - Hôpital Cochin, Université Paris XI Sud - Gustave Roussy Cancer Campus, Institut Universitaire du Cancer, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, University of Lille II - Centre Hospitalier Régional de Lille, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Ambroise Paré Hospital (AP-HP), Université Paris XI Sud - Gustave Roussy Cancer Campus, Institute Jules Bordet - Department of Haematology, Centre Médical de L'Archipel, Les Hôpitaux Universitaires de Strasbourg, Centre Hospitalier Universitaire (CHU) de Bordeaux, Hôpital Morvan Centre Hospitalier Régional Universitaire de Brest, Centre Hospitalier Régional Universitaire Jean Minjoz, Aix Marseille Université - CNRS, INSERM, CIML, Université Paris XI Sud - Gustave Roussy Cancer Campus, Hôpital Européen Georges Pompidou, APHP, Centre Hospitalier de La Rochelle, Hôpital André Mignot, Francis Crick Institute - Haematopoietic Stem Cell Laboratory, Université Paris XI Sud - Gustave Roussy Cancer Campus, Etablissement Français du Sang, Université Paris XI Sud - Gustave Roussy Cancer Campus, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Université Paris XI Sud - Gustave Roussy Cancer Campus, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor and Le Commissariat à l’énergie atomique et aux énergies alternatives (CEA)
Downloads 2 (629,977)

Abstract:

Loading...

Immune-related adverse events; Anti-programmed cell death 1; Anti-programmed cell death ligand 1; Neutropenia; Autoimmune hemolytic anemia; Aplastic anemia; Pancytopenia; Immune thrombocytopenia; Pure-red cell aplasia